Common Contracts
6 similar Placement Agent Agreement contracts by Discovery Laboratories Inc /De/, GTC Biotherapeutics Inc, Genvec Inc
3,030,304 Shares DISCOVERY LABORATORIES, INC. Shares of Common Stock ($0.001 par value) PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • December 14th, 2005 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
Discovery Laboratories, Inc., a Delaware corporation (the “Company”), proposes to sell to the Purchasers, pursuant to the terms of this Placement Agent Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the Purchasers identified therein (each a “Purchaser” and, collectively, the “Purchasers”), an aggregate of 3,030,304 shares of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company. The aggregate of 3,030,304 shares so proposed to be sold is hereinafter referred to as the “Stock.” The Company hereby confirms its agreement with SG Cowen & Co., LLC (“SG Cowen”) as follows (certain terms used herein are defined in Section 14 hereof):
Shares of Common Stock ($0.001 par value) PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • September 21st, 2005 • Genvec Inc • Pharmaceutical preparations • New York
GenVec, Inc., a Delaware corporation (the “Company”), pursuant to the terms of this Placement Agent Agreement (this “Agreement”) and the Purchase Agreements in the form of Exhibit A attached hereto (the “Purchase Agreements”) entered into with the purchasers identified therein (each a “Purchaser” and, collectively, the “Purchasers”), proposes to sell to the Purchasers an aggregate of 7,650,000 shares of Common Stock, par value $0.001 per share, together with associated stock purchase rights (the “Common Stock”) of the Company. The aggregate of 7,650,000 shares of Common Stock so proposed to be sold by the Company is hereinafter referred to as the “Stock.” The Company hereby confirms its agreement with SG Cowen & Co., LLC (“SG Cowen” or the “Placement Agent”) as follows (certain terms herein are defined in Section 13 hereof):
4,610,000 Shares DISCOVERY LABORATORIES, INC. Shares of Common Stock ($0.001 par value) PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • February 18th, 2005 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
Discovery Laboratories, Inc., a Delaware corporation (the “Company”), proposes to sell to the Purchasers, pursuant to the terms of this Placement Agent Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the Purchasers identified therein (each a “Purchaser” and, collectively, the “Purchasers”), an aggregate of 4,610,000 shares of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company. The aggregate of 4,610,000 shares so proposed to be sold is hereinafter referred to as the “Stock.” The Company hereby confirms its agreement with SG Cowen & Co., LLC (“SG Cowen”) as follows (certain terms used herein are defined in Section 13 hereof):
450,000 Shares DISCOVERY LABORATORIES, INC. Shares of Common Stock ($0.001 par value) PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • February 18th, 2005 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
Discovery Laboratories, Inc., a Delaware corporation (the “Company”), proposes to sell to the Purchasers, pursuant to the terms of this Placement Agent Agreement (this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto (the “Subscription Agreements”) entered into with the Purchasers identified therein (each a “Purchaser” and, collectively, the “Purchasers”), an aggregate of 450,000 shares of Common Stock, par value $0.001 per share (the “Common Stock”), of the Company. The aggregate of 450,000 shares so proposed to be sold is hereinafter referred to as the “Stock.” The Company hereby confirms its agreement with SG Cowen & Co., LLC (“SG Cowen”) as follows (certain terms used herein are defined in Section 13 hereof):
7,740,739 Shares GTC BIOTHERAPEUTICS, INC. Shares of Common Stock ($.01 par value) PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • January 25th, 2005 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • New York
GTC Biotherapeutics, Inc., a Massachusetts corporation (the “Company”), proposes to issue and sell to the Purchasers, pursuant to the terms of this Placement Agent Agreement (this “Agreement”) and the Subscription Agreements, in a form to be agreed upon (the “Subscription Agreements”) and entered into severally with the Purchasers that become parties thereto (each a “Purchaser” and, collectively, the “Purchasers”), an aggregate of 7,740,739 shares of Common Stock, $.01 par value (the “Common Stock”), of the Company. The aggregate of 7,740,739 shares so proposed to be sold is hereinafter referred to as the “Stock.” The Company hereby confirms its agreement with SG Cowen & Co., LLC (“SG Cowen”) as follows (certain capitalized terms used herein are defined in Section 13 hereof):
6,395,298 Shares GTC BIOTHERAPEUTICS, INC. Shares of Common Stock ($.01 par value) PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • March 16th, 2004 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • New York
SG COWEN SECURITIES CORPORATION RODMAN & RENSHAW, LLC c/o SG Cowen Securities Corporation 1221 Avenue of the Americas New York, New York 10020
